Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Drought stress modulates secondary metabolites in Brassica oleracea L. convar. acephala (DC) Alef, var. sabellica L.

Podda A, Pollastri S, Bartolini P, Pisuttu C, Pellegrini E, Nali C, Cencetti G, Michelozzi M, Frassinetti S, Giorgetti L, Fineschi S, Del Carratore R, Maserti B.

J Sci Food Agric. 2019 May 20. doi: 10.1002/jsfa.9816. [Epub ahead of print]

PMID:
31106430
2.

Posterior interosseous nerve of the elbow at the arcade of Frohse: Ultrasound appearance in asymptomatic subjects.

Ceri T, Podda A, Behr J, Brumpt E, Alilet M, Aubry S.

Diagn Interv Imaging. 2019 Mar 29. pii: S2211-5684(19)30064-6. doi: 10.1016/j.diii.2019.03.007. [Epub ahead of print]

PMID:
30935861
3.

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.

Launay O, Ndiaye AGW, Conti V, Loulergue P, Sciré AS, Landre AM, Ferruzzi P, Nedjaai N, Schütte LD, Auerbach J, Marchetti E, Saul A, Martin LB, Podda A.

Front Immunol. 2019 Mar 8;10:335. doi: 10.3389/fimmu.2019.00335. eCollection 2019.

4.

Artifacts and Technical Restrictions in 2D Shear Wave Elastography.

Bouchet P, Gennisson JL, Podda A, Alilet M, Carrié M, Aubry S.

Ultraschall Med. 2018 Dec 21. doi: 10.1055/a-0805-1099. [Epub ahead of print]

PMID:
30577047
5.

Can nutrient fertilization mitigate the effects of ozone exposure on an ozone-sensitive poplar clone?

Podda A, Pisuttu C, Hoshika Y, Pellegrini E, Carrari E, Lorenzini G, Nali C, Cotrozzi L, Zhang L, Baraldi R, Neri L, Paoletti E.

Sci Total Environ. 2019 Mar 20;657:340-350. doi: 10.1016/j.scitotenv.2018.11.459. Epub 2018 Nov 30.

PMID:
30550899
6.

Root colonization by Pseudomonas chlororaphis primes tomato (Lycopersicum esculentum) plants for enhanced tolerance to water stress.

Brilli F, Pollastri S, Raio A, Baraldi R, Neri L, Bartolini P, Podda A, Loreto F, Maserti BE, Balestrini R.

J Plant Physiol. 2019 Jan;232:82-93. doi: 10.1016/j.jplph.2018.10.029. Epub 2018 Nov 16.

PMID:
30537616
7.

Cross-talk between physiological and biochemical adjustments by Punica granatum cv. Dente di cavallo mitigates the effects of salinity and ozone stress.

Calzone A, Podda A, Lorenzini G, Maserti BE, Carrari E, Deleanu E, Hoshika Y, Haworth M, Nali C, Badea O, Pellegrini E, Fares S, Paoletti E.

Sci Total Environ. 2019 Mar 15;656:589-597. doi: 10.1016/j.scitotenv.2018.11.402. Epub 2018 Nov 28.

PMID:
30529963
8.

Education in Vaccinology: An Important Tool for Strengthening Global Health.

Lambert PH, Podda A.

Front Immunol. 2018 May 24;9:1134. doi: 10.3389/fimmu.2018.01134. eCollection 2018. Review.

9.

Novel Therapy for Pediatric Angiosarcoma With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Winer L, Macedo FI, Alfawaz A, Sommariva A, Cecchetto G, Podda A, Neville HL, Möller MG.

J Pediatr Hematol Oncol. 2018 Nov;40(8):e505-e510. doi: 10.1097/MPH.0000000000001231.

PMID:
29863582
10.

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.

Obiero CW, Ndiaye AGW, Sciré AS, Kaunyangi BM, Marchetti E, Gone AM, Schütte LD, Riccucci D, Auerbach J, Saul A, Martin LB, Bejon P, Njuguna P, Podda A.

Front Immunol. 2017 Dec 22;8:1884. doi: 10.3389/fimmu.2017.01884. eCollection 2017.

11.

A L-type lectin gene is involved in the response to hormonal treatment and water deficit in Volkamer lemon.

Vieira DDSS, Emiliani G, Bartolini P, Podda A, Centritto M, Luro F, Del Carratore R, Morillon R, Gesteira A, Maserti B.

J Plant Physiol. 2017 Nov;218:94-99. doi: 10.1016/j.jplph.2017.07.020. Epub 2017 Aug 1.

PMID:
28802186
12.

Ultrasound elastography in tendon pathology: state of the art.

Domenichini R, Pialat JB, Podda A, Aubry S.

Skeletal Radiol. 2017 Dec;46(12):1643-1655. doi: 10.1007/s00256-017-2726-2. Epub 2017 Aug 1. Review.

PMID:
28765991
13.

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.

Launay O, Lewis DJM, Anemona A, Loulergue P, Leahy J, Sciré AS, Maugard A, Marchetti E, Zancan S, Huo Z, Rondini S, Marhaba R, Finco O, Martin LB, Auerbach J, Cohen D, Saul A, Gerke C, Podda A.

EBioMedicine. 2017 Aug;22:164-172. doi: 10.1016/j.ebiom.2017.07.013. Epub 2017 Jul 15.

14.

Angiosarcoma of the Pelvis in a 13-Year-Old Girl.

El-Sharkawy F, Delgado PI, Podda A, Neville HL, Rojas CP.

Pediatr Dev Pathol. 2017 Mar-Apr;20(2):163-167. doi: 10.1177/1093526616686007. Epub 2017 Jan 26. Review.

PMID:
28326959
15.

Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.

Dobinson HC, Gibani MM, Jones C, Thomaides-Brears HB, Voysey M, Darton TC, Waddington CS, Campbell D, Milligan I, Zhou L, Shrestha S, Kerridge SA, Peters A, Stevens Z, Podda A, Martin LB, D'Alessio F, Thanh DP, Basnyat B, Baker S, Angus B, Levine MM, Blohmke CJ, Pollard AJ.

Clin Infect Dis. 2017 Apr 15;64(8):1066-1073. doi: 10.1093/cid/cix042.

16.

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.

Muturi-Kioi V, Lewis D, Launay O, Leroux-Roels G, Anemona A, Loulergue P, Bodinham CL, Aerssens A, Groth N, Saul A, Podda A.

PLoS One. 2016 Aug 4;11(8):e0157385. doi: 10.1371/journal.pone.0157385. eCollection 2016. Review.

17.

The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.

Thompson CN, Le TP, Anders KL, Nguyen TH, Lu LV, Nguyen VV, Vu TD, Nguyen NM, Tran TH, Ha TT, Tran VT, Pham VM, Tran do HN, Le TQ, Saul A, Martin LB, Podda A, Gerke C, Thwaites G, Simmons CP, Baker S.

Vaccine. 2016 Feb 3;34(6):783-90. doi: 10.1016/j.vaccine.2015.12.047. Epub 2015 Dec 29.

18.

Proteome changes during yeast-like and pseudohyphal growth in the biofilm-forming yeast Pichia fermentans.

Maserti B, Podda A, Giorgetti L, Del Carratore R, Chevret D, Migheli Q.

Amino Acids. 2015 Jun;47(6):1091-106. doi: 10.1007/s00726-015-1933-1. Epub 2015 Mar 6.

PMID:
25743163
19.

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.

Lancet Infect Dis. 2014 Feb;14(2):119-29. doi: 10.1016/S1473-3099(13)70241-X. Epub 2013 Nov 28.

PMID:
24290843
20.

Expression profiling of two stress-inducible genes encoding for miraculin-like proteins in citrus plants under insect infestation or salinity stress.

Podda A, Simili M, Del Carratore R, Mouhaya W, Morillon R, Maserti BE.

J Plant Physiol. 2014 Jan 1;171(1):45-54. doi: 10.1016/j.jplph.2013.08.001. Epub 2013 Aug 31.

PMID:
24001970
21.

Nosocomial Herpes Encephalitis: rare but treatable with early MR diagnosis.

Doshi P, Donovan Post MJ, Saigal G, Podda A, Quencer R.

Neuroradiol J. 2013 Apr;26(2):168-74. Epub 2013 May 10.

22.

Salt-stress induced changes in the leaf proteome of diploid and tetraploid mandarins with contrasting Na+ and Cl- accumulation behaviour.

Podda A, Checcucci G, Mouhaya W, Centeno D, Rofidal V, Del Carratore R, Luro F, Morillon R, Ollitrault P, Maserti BE.

J Plant Physiol. 2013 Aug 15;170(12):1101-12. doi: 10.1016/j.jplph.2013.03.006. Epub 2013 Apr 19.

PMID:
23608743
23.

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults.

van Damme P, Kafeja F, Anemona A, Basile V, Hilbert AK, De Coster I, Rondini S, Micoli F, Qasim Khan RM, Marchetti E, Di Cioccio V, Saul A, Martin LB, Podda A.

PLoS One. 2011;6(9):e25398. doi: 10.1371/journal.pone.0025398. Epub 2011 Sep 30.

24.

Increased prevalence of false positive hemoglobinopathy newborn screening in premature infants.

Hustace T, Fleisher JM, Sanchez Varela AM, Podda A, Alvarez O.

Pediatr Blood Cancer. 2011 Dec 1;57(6):1039-43. doi: 10.1002/pbc.23173. Epub 2011 May 16.

PMID:
21584936
25.

A stress responsive alternative splicing mechanism in Citrus clementina leaves.

Del Carratore R, Magaldi E, Podda A, Beffy P, Migheli Q, Maserti BE.

J Plant Physiol. 2011 Jun 15;168(9):952-9. doi: 10.1016/j.jplph.2010.11.016. Epub 2011 Feb 18.

PMID:
21310505
26.

Comparative analysis of proteome changes induced by the two spotted spider mite Tetranychus urticae and methyl jasmonate in citrus leaves.

Maserti BE, Del Carratore R, Croce CM, Podda A, Migheli Q, Froelicher Y, Luro F, Morillon R, Ollitrault P, Talon M, Rossignol M.

J Plant Physiol. 2011 Mar 1;168(4):392-402. doi: 10.1016/j.jplph.2010.07.026.

PMID:
20926159
27.

Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: application of a re-sampling method on a large phase III influenza vaccine clinical trial.

Bugarini R, Casula D, Groth N, Lattanzi M, Holmes S, Podda A.

Vaccine. 2010 Oct 28;28(46):7401-6. doi: 10.1016/j.vaccine.2010.08.102. Epub 2010 Sep 16.

PMID:
20850533
28.

Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009.

Podda A, Saul AJ, Arora R, Bhutta Z, Sinha A, Gaind R, Singhal T, Saha S, Brooks A, Martin LB, Amdekar Y, Chitkara AJ, Shieh M, Kapur AN, Chugh TD.

J Infect Dev Ctries. 2010 Jun 30;4(6):404-11.

29.

Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.

Szymczakiewicz-Multanowska A, Groth N, Bugarini R, Lattanzi M, Casula D, Hilbert A, Tsai T, Podda A.

J Infect Dis. 2009 Sep 15;200(6):841-8. doi: 10.1086/605505. Erratum in: J Infect Dis. 2009 Dec 1;200(11):1801-2.

PMID:
19673651
30.

A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.

Ambrozaitis A, Groth N, Bugarini R, Sparacio V, Podda A, Lattanzi M.

Vaccine. 2009 Oct 9;27(43):6022-9. doi: 10.1016/j.vaccine.2009.07.083. Epub 2009 Aug 8.

PMID:
19666152
31.

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.

Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A.

Pediatr Infect Dis J. 2009 Jul;28(7):563-71. doi: 10.1097/INF.0b013e31819d6394.

PMID:
19561422
32.

MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.

Banzhoff A, Pellegrini M, Del Giudice G, Fragapane E, Groth N, Podda A.

Influenza Other Respir Viruses. 2008 Nov;2(6):243-9. doi: 10.1111/j.1750-2659.2008.00059.x. Review.

33.

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults.

Banzhoff A, Gasparini R, Laghi-Pasini F, Staniscia T, Durando P, Montomoli E, Capecchi PL, di Giovanni P, Sticchi L, Gentile C, Hilbert A, Brauer V, Tilman S, Podda A.

PLoS One. 2009;4(2):e4384. doi: 10.1371/journal.pone.0004384. Epub 2009 Feb 6. Erratum in: PLoS ONE. 2009;4(3). doi: 10.1371/annotation/5f2ae0fb-53f1-48c2-aa19-9114765ba029. Capecchi, Pamela [corrected to Capecchi, Pier Leopoldo].

34.

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

Groth N, Montomoli E, Gentile C, Manini I, Bugarini R, Podda A.

Vaccine. 2009 Jan 29;27(5):786-91. doi: 10.1016/j.vaccine.2008.11.003. Epub 2008 Nov 21.

PMID:
19027046
35.

Placental site trophoblastic tumor in the ovary of a young child with isosexual precocious puberty.

Arroyo MR, Podda A, Cao D, Rodriguez MM.

Pediatr Dev Pathol. 2009 Jan-Feb;12(1):73-6. doi: 10.2350/08-05-0462.1.

PMID:
18671454
36.

Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects.

Li R, Fang H, Li Y, Liu Y, Pellegrini M, Podda A.

Immun Ageing. 2008 Feb 20;5:2. doi: 10.1186/1742-4933-5-2.

37.

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, Sticchi L, Renzoni A, Fabbri P, Ferrera A, Parodi A, Bruzzone B, Gabutti G, Podda A, Del Giudice G, Fragapane E, Indiveri F, Crovari P, Gasparini R.

Clin Vaccine Immunol. 2008 Feb;15(2):253-9. Epub 2007 Nov 14.

38.

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

O'Hagan DT, Wack A, Podda A.

Clin Pharmacol Ther. 2007 Dec;82(6):740-4. Epub 2007 Oct 31. Review.

PMID:
17971820
39.

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.

Del Giudice G, Fragapane E, Bugarini R, Hora M, Henriksson T, Palla E, O'hagan D, Donnelly J, Rappuoli R, Podda A.

Clin Vaccine Immunol. 2006 Sep;13(9):1010-3.

40.

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.

Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, Mills KH, Nicholson KG.

J Virol. 2006 May;80(10):4962-70.

41.

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.

Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A.

Vaccine. 2006 Apr 12;24(16):3063-5. Epub 2006 Jan 19.

PMID:
16464520
42.

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

Stephenson I, Bugarini R, Nicholson KG, Podda A, Wood JM, Zambon MC, Katz JM.

J Infect Dis. 2005 Apr 15;191(8):1210-5. Epub 2005 Mar 14.

PMID:
15776364
43.

Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement.

Azouz EM, Saigal G, Rodriguez MM, Podda A.

Pediatr Radiol. 2005 Feb;35(2):103-15. Epub 2004 Jul 28. Review.

PMID:
15289942
44.
45.

Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines.

Matjila MJ, Phohu TC, Banzhoff A, Viviani S, Hoosen AA, Bianchini M, Nacci P, Palweni CW, Podda A, Whitfield M, Aspinall S.

S Afr Med J. 2004 Jan;94(1):43-6.

47.
48.

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.

Peppoloni S, Ruggiero P, Contorni M, Morandi M, Pizza M, Rappuoli R, Podda A, Del Giudice G.

Expert Rev Vaccines. 2003 Apr;2(2):285-93. Review.

PMID:
12899578
49.

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.

Podda A, Del Giudice G.

Expert Rev Vaccines. 2003 Apr;2(2):197-203. Review.

PMID:
12899571
50.

Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.

Kanra G, Viviani S, Yurdakök K, Ozmert E, Anemona A, Yalçin S, Demiralp O, Bilgili N, Kara A, Cengiz AB, Mutlu B, Baldini A, Marchetti E, Podda A.

Pediatr Int. 2003 Jun;45(3):314-8.

PMID:
12828588

Supplemental Content

Support Center